Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

7:08 AM ET 8-K
Financial Results Yarrow Bioscience, Inc. YARW

Yarrow Bioscience Financial Results

Yarrow Bioscience reported third quarter 2026 financial results, ending the period with $268.9 million in cash following a $172.5 million public offering. The company is currently enrolling patients in its Phase 2a/2b DIRECTION-GD trial for YB-101, with topline data expected in the second half of 2027.

“We made significant progress in the third quarter, including dosing our first patient in the Phase 2a portion of the DIRECTION-GD trial and strengthening our balance sheet through the completion of our merger and subsequent public offering. The financing extends our expected cash runway into 2030 and positions us to advance YB-101 in Graves’ disease and prepare for our next steps in thyroid eye disease.”

Rebecca V. Frey, PharmD, President and Chief Executive Officer
7:08 AM ET 8-K
Financial Results Octave Intelligence plc OCTV

Octave Intelligence Financial Results

Octave Intelligence reported Q3 2026 financial results with total revenue of $415 million and net income of $59 million. The company also announced that its Board of Directors approved a new $200 million share repurchase program, reflecting confidence in its recurring revenue strategy and free cash flow growth.

“Our third quarter results were in line with our expectations, and we remain on track to achieve our outlook for the full year. ARR grew 7% over the prior year to $1.17 billion, and SaaS revenue grew 18%, as we continue our focused shift toward recurring revenue. Product innovation and go-to-market improvements continued to gain traction this quarter, and we’re carrying that momentum into the fourth quarter”

Mattias Stenberg, Chief Executive Officer

“Additionally, our Board of Directors recently approved a $200 million share repurchase program, a decision that reflects its confidence in our company strategy, medium-term financial targets, and ability to grow free cash flow.”

Mattias Stenberg, Chief Executive Officer
7:07 AM ET 10-Q
Financial Results Century Therapeutics, Inc. IPSC

Century Therapeutics Q3 2026 Results: Net Loss of $23.5M, Loss Narrows

Century Therapeutics reported a total asset increase to $262.6 million as of September 30, 2026, driven by a significant increase in common stock issuance and long-term investments. The company's accumulated deficit grew to $871.6 million, reflecting ongoing development costs for its iPSC-derived immune cell therapies.

Key figure
Net loss $23.5M
7:06 AM ET 10-Q
Financial Results Generate Biomedicines, Inc. GENB

Generate Biomedicines Q3 2026 Results: Net Loss of $87.7M, Loss Widens

Generate Biomedicines, Inc. is a clinical-stage biotechnology company utilizing its AI-driven 'Generate Platform' for drug discovery. As of October 29, 2026, the company had 129,096,666 shares of common stock outstanding and is classified as an emerging growth company and a non-accelerated filer.

Key figure
Net loss $87.7M
7:06 AM ET 10-Q
Financial Results Standard Nuclear, Inc. STDN

Standard Nuclear Q3 2026 Results: Net Loss of $13.1M, Loss Widens

Standard Nuclear, Inc. reported a significant revenue increase to $11.3 million for the first nine months of 2026, driven by new product revenue, though it maintained a net loss of $24.2 million. The company successfully completed an IPO and a 2-for-1 stock split, ending the period with a substantially strengthened cash position of $223.1 million.

Key figure
Net loss $13.1M
7:05 AM ET 8-K
Financial Results Cyngn Inc. CYN

Cyngn Financial Results

Cyngn Inc. reported its Q3 2026 financial results, highlighting year-to-date revenue of $405.5 thousand and a cash position of $34.9 million with no debt. The company noted commercial progress including a follow-on order from a Fortune 100 heavy equipment manufacturer and the launch of its DriveMod EasyLaunch program to lower adoption barriers for autonomous industrial vehicles.

7:05 AM ET 8-K
Financial Results EyePoint, Inc. EYPT

EyePoint Financial Results

EyePoint reported Q3 2026 financial results and announced a strategic prioritization of its DURAVYU Phase 3 program in Diabetic Macular Edema (DME). The company expects this prioritization to generate $30 million in annualized savings following mixed Phase 3 results in wet AMD.

“The recent Phase 3 wet AMD data demonstrated DURAVYU’s ability to control fluid and maintain retinal anatomy through Week 56, along with a favorable safety profile that included every six-month redosing. This important data supports our strategic decision to prioritize our resources on DME, where we believe there is strong scientific and clinical rationale for DURAVYU as a durable treatment option for this vision threatening exudative disease.”

Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint
7:04 AM ET 10-Q
Financial Results Mobility Global Inc. MBGL

Mobility Global Q3 2026 Results: Net Income $42M, Down 40.8% YoY

Mobility Global Inc. completed its separation from S&P Global on July 1, 2026, becoming an independent publicly traded company. For the nine months ended September 30, 2026, the company reported revenue of $1,401 million and net income of $150 million, compared to $1,304 million and $194 million in the prior year period, respectively.

Key figure
Net income $42M · -40.8% YoY
7:03 AM ET 8-K
Financial Results Mobility Global Inc. MBGL

Mobility Global Financial Results

Mobility Global reported its first full quarter as a standalone public company, with revenue increasing 7.4% year-over-year to $478 million. The company reported net income of $42 million and adjusted EBITDA of $195 million, while also authorizing a new $800 million share repurchase program.

Term
Q3 2026

“Our first full quarter as a standalone public company was a solid one, with growth stepping up from the first half across both segments. We are bringing our CARFAX and B2B businesses together as One Mobility Global and applying AI to our proprietary data, trusted brands and deeply embedded customer relationships to deliver more value to our customers and drive growth.”

Bill Eager, Chief Executive Officer of Mobility Global
7:03 AM ET 10-Q
Financial Results NIQ Global Intelligence plc NIQ ▶ Call

NIQ Global Intelligence Q3 2026 Results: Turns Profitable, Net Income $35.8M

For the quarter ended September 30, 2026, NIQ Global Intelligence reported revenues of $1,119.1 million and net income attributable to NIQ of $35.8 million, a significant improvement from the $198.6 million loss in the prior year period. The company's balance sheet shows $572.6 million in cash and total debt of approximately $3.55 billion as of the end of the third quarter.

Key figure
Net income $35.8M
7:03 AM ET 8-K
Financial Results BK Technologies Corp BKTI

BK Technologies Financial Results

BK Technologies reported record third-quarter revenue of $25.3 million, driven by strong federal demand and the adoption of its BKR 5000 Orange radio by the U.S. Forest Service. The company achieved a gross margin of 50.7% and grew its cash position to $29.2 million with no debt. Additionally, the company doubled its share repurchase authorization to $10 million and made a $3.0 million strategic investment in software provider Tango Tango.

Term
Q3 2026

“Our third quarter results underscore the durability of our business model and demonstrate our ability to consistently deliver profitable growth. Federal demand was a key growth driver leading to record third quarter revenue of $25.3 million, a gross margin above 50% and an increase in net income of 9% that outpaced revenue growth.”

John Suzuki, CEO of BK Technologies
7:02 AM ET 8-K
Financial Results Kardigan, Inc. KARD

Kardigan Financial Results

Kardigan, Inc. reported third quarter 2026 financial results, ending the period with $591.4 million in cash to fund operations through 2027. The company achieved significant clinical milestones, including completing enrollment in the Phase 2b portion of its danicamtiv KINSHIP-DCM trial and the Phase 2b KATALYST-AV trial for ataciguat. Topline data for the danicamtiv trial is expected in the second quarter of 2027.

Term
Q3 2026

“We made meaningful progress this quarter in advancing our portfolio of late-stage cardiovascular programs for people who urgently need better treatment options. Completing enrollment in the Phase 2b portion of our Phase 2b/3 adaptive KINSHIP-DCM trial is a significant milestone for danicamtiv and for people with genetic dilated cardiomyopathy.”

Tassos Gianakakos, co-founder, chief executive officer and board chair
7:02 AM ET 10-Q
Financial Results BCP Investment Corp BCIC ▶ Call

BCP Investment Q3 2026 Results: Net Loss of $13.5M

BCP Investment Corp reported total investment income of $34.8 million for the nine months ended September 30, 2026, compared to $31.1 million in the prior year period. The company's Net Asset Value (NAV) per share decreased to $13.13 from $16.68 at year-end 2025, while total assets declined to $449.5 million as the company manages its portfolio and prepares for a potential merger with Investcorp Credit Management BDC, Inc.

Key figure
Net loss $13.5M
7:02 AM ET 8-K
Financial Results Kiora Pharmaceuticals Inc KPRX

Kiora Pharmaceuticals Financial Results

Kiora Pharmaceuticals reported third quarter 2026 financial results and highlighted the strategic in-licensing of KIO-401, a late-stage oral neuroprotective asset for retinal diseases. The company ended the quarter with $16.3 million in cash and is preparing for a Phase 3 registration trial for KIO-401 in patients with Central Retinal Artery Occlusion (CRAO).

“The addition of KIO-401 transforms Kiora into a late-stage retinal therapeutics company. We are building on the significant amount of CMC, non-clinical and clinical data that already exists on KIO-401 through Senju’s previous and ongoing efforts. With exclusive rights outside Asia, we are preparing for a single, phase 3, registration trial of KIO-401 in patients across the United States, Europe and other territories.”

Brian M. Strem, Ph.D., President and Chief Executive Officer
7:02 AM ET 8-K
Financial Results NIQ Global Intelligence plc NIQ

NIQ Global Intelligence Financial Results

NIQ Global Intelligence reported Q3 2026 financial results, achieving positive GAAP EPS for the first time since its IPO with revenue of $1.12 billion. The company also announced a new $150 million share repurchase program and raised its full-year 2026 guidance following six consecutive quarters of exceeding targets.

“Q3 was a milestone quarter — we exceeded the top end of our guidance across all key metrics for the sixth consecutive quarter, delivered positive GAAP earnings per share for the first time since our IPO, and reached our net leverage milestone a quarter ahead of plan.”

Jim Peck, Executive Chairman and Chief Executive Officer
7:02 AM ET 10-Q
Financial Results RCM Technologies, Inc. RCMT

RCM Technologies Q3 2026 Results: Net Income $2.72M, Up 20.2% YoY

RCM Technologies reported net income of $11.5 million for the thirty-nine weeks ended October 3, 2026, an increase from $10.2 million in the prior year period. Revenue grew to $250.3 million compared to $232.9 million, while the company continued its share repurchase program, increasing treasury stock to $91.4 million.

Key figure
Net income $2.72M · +20.2% YoY
7:01 AM ET 10-Q
Financial Results Kiora Pharmaceuticals Inc KPRX

Kiora Pharmaceuticals Q3 2026 Results: Net Loss of $1.75M

Kiora Pharmaceuticals reported a net loss of $1.75 million for the third quarter of 2026, compared to a small net income of $0.03 million in the prior year period. While the company recognized $1.0 million in collaboration revenue, total operating expenses increased significantly due to a $1.77 million unfavorable swing in the fair value of contingent consideration.

Key figure
Net loss $1.75M
7:01 AM ET 10-Q
Financial Results Chicago Atlantic BDC, Inc. LIEN ▶ Call

Chicago Atlantic BDC Q3 2026 Results: Net Income $8.01M, Down 9.3% YoY

Chicago Atlantic BDC, Inc. reported total investment income of $46.1 million for the nine months ended September 30, 2026, compared to $40.1 million for the same period in 2025. The company is currently in the process of a merger with Chicago Atlantic Real Estate Finance, Inc. (REFI), which is expected to result in REFI merging into the Company.

Key figure
Net income $8.01M · -9.3% YoY
7:01 AM ET 8-K
Financial Results Chicago Atlantic BDC, Inc. LIEN

Chicago Atlantic BDC Financial Results

Chicago Atlantic BDC reported Q3 2026 financial results with total investment income of $15.4 million and net investment income of $8.3 million ($0.36 per share). The company achieved record year-to-date gross originations of $167.4 million, growing its portfolio to its largest size in history with a focus on cannabis operators and lower middle market lending.

“The third quarter continued to show that Chicago Atlantic BDC is uniquely positioned to generate attractive risk adjusted returns with a disciplined focus on capital preservation. This has been a record year for gross originations thus far: we have deployed $167.4 million year to date, including, $72.0 million to two new borrowers in the third quarter, growing the portfolio to the largest size in company history.”

Peter Sack, Chief Executive Officer of the Company

“Our differentiated investment approach has produced a strong and resilient portfolio characterized by stable risk ratings, no investments on non-accrual, and a 100% senior secured debt portfolio, generating a weighted average yield of 15.5%.”

Peter Sack, Chief Executive Officer of the Company
7:01 AM ET 10-Q
Financial Results Bit Digital, Inc BTBT ▶ Call

Bit Digital Q3 2026 Results: Net Income $28.5M, Down 81.1% YoY

Bit Digital, Inc. reported various investment activities for the quarter ended September 30, 2026, including a $1.0 million SAFE investment in Canopy Wave Inc. and a $33.7 million total investment in AI Innovation Fund I. The company also recorded significant fair value adjustments, notably a $17.1 million upward adjustment for its Innovation Fund I during the three-month period.

Key figure
Net income $28.5M · -81.1% YoY
7:01 AM ET 10-Q
Financial Results Aveanna Healthcare Holdings, Inc. AVAH

Aveanna Healthcare Holdings Q3 2026 Results: Net Income $45.5M, Up 223.2% YoY

Aveanna Healthcare reported revenue of $695.5 million for the third quarter of 2026, up from $621.9 million in the prior year period. The company significantly reduced its accumulated deficit from $1.16 billion at the start of the year to $1.03 billion as of October 3, 2026, while total assets grew to $2.21 billion following the acquisition of Family First Holding, LLC.

Key figure
Net income $45.5M · +223.2% YoY
7:01 AM ET 8-K
Financial Results Hyperion Defi, Inc. HYPD

Hyperion Defi Financial Results

Hyperion DeFi reported record Q3 2026 net income of $39.6 million, marking its third consecutive quarterly record and achieving breakeven core operating profit ahead of schedule. The company also announced that it has retired all legacy debt and commenced share repurchases while growing its digital asset holdings to $108.8 million.

Term
Q3 2026

“We are pleased to report a third consecutive quarter of record Net Income and, importantly, our first quarter of breakeven-or-better core operating profit and cash flows, achieved one quarter ahead of our initial 2026 year-end target”

Hyunsu Jung, CEO of Hyperion DeFi

“With our legacy debt now retired, share repurchases underway, and our core operations having achieved the inflection point we promised since day one, we continue to position ourselves as the premier institutional gateway to DeFi innovation as we deliver on our mission to revolutionize blockchain financial services.”

Hyunsu Jung, CEO of Hyperion DeFi
7:01 AM ET 8-K
Financial Results Fermi Inc. FRMI

Fermi Financial Results

Fermi Inc. reported Q3 2026 financial results and announced new agreements with an undisclosed investment-grade hyperscaler for 600 MW of power capacity at Project Matador. The hyperscaler committed $200 million in upfront funding and $15 million for early construction, while a previous lease agreement with TensorWave was terminated.

“Hyperscalers want sites that are ready with permitted power, and Fermi’s Project Matador is one of few that can meet that demand today. Our headstart in speed to power is a key reason an investment-grade hyperscaler has signed up for 600 megawatts and committed more than $200 million up front to accelerate construction at Project Matador with an additional $90 million contemplated.”

Lee McIntire, Fermi Chief Executive Officer
7:01 AM ET 8-K
Financial Results Broadwind, Inc. BWEN

Broadwind Financial Results

Broadwind reported Q3 2026 revenue of $22.3 million, a 48% increase year-over-year, driven by its strategic shift toward domestic power generation and critical infrastructure. The company reported a GAAP loss from continuing operations of $1.0 million and highlighted its recent acquisition of MCM to capitalize on domestic grid expansion.

Term
Q3 2026

“During the third quarter, we continued to execute on our strategic transformation into a pure-play precision manufacturing business focused on the domestic power generation and critical infrastructure markets.”

Eric Blashford, President and CEO of Broadwind

“Last week, we announced our first acquisition in nearly a decade with the purchase of MCM. MCM is a vertically integrated component supplier serving the domestic electrical transmission and distribution sector.”

Eric Blashford, President and CEO of Broadwind
7:01 AM ET 10-Q
Financial Results Aebi Schmidt Holding AG AEBI ▶ Call

Aebi Schmidt Holding Q3 2026 Results: Net Income $10.8M, Up 796.7% YoY

Aebi Schmidt Holding AG reported a significant increase in nine-month sales to $1.45 billion in 2026 compared to $998 million in 2025, driven by business combinations. Net income for the nine months ended September 30, 2026, rose to $21.9 million, a substantial improvement from $0.9 million in the prior year period.

Key figure
Net income $10.8M · +796.7% YoY
7:01 AM ET 8-K
Financial Results Standard Nuclear, Inc. STDN

Standard Nuclear Financial Results

Standard Nuclear reported Q3 2026 financial results, highlighting a significant revenue increase to $6.0 million and a total contract backlog that more than doubled to $577.2 million. The company completed its first commercial reactor core delivery and is nearing completion of new production facilities in Tennessee and Idaho, with operational authorization targeted for February 2027.

Term
Q3 2026

“Advanced nuclear deployment depends on industrial-scale fuel supply, and this quarter we delivered. We delivered our first reactor core, more than doubled our Total Contract Backlog, and submitted the final Documented Safety Analysis for our Tennessee facility, the first of the two identical Hazard Category 2 facilities we are deploying in Tennessee and Idaho.”

Kurt Terrani, President and Chief Executive Officer
7:01 AM ET 8-K
Financial Results Aebi Schmidt Holding AG AEBI

Aebi Schmidt Holding Financial Results

Aebi Schmidt reported Q3 2026 net sales of $493 million, up 4.6% year-over-year, driven by strong performance in its North American Walk-In Van operations. Net income improved significantly to $10.8 million compared to $1.2 million in the prior year quarter, despite gross margin pressure from inflationary costs. The company updated its full-year 2026 guidance, projecting net sales between $1.95 billion and $2.00 billion.

Term
Q3 2026

“Aebi Schmidt delivered a solid performance navigating a challenging market environment marked by cost inflation, geopolitical uncertainty, and supply chain disruptions. We responded quickly by accelerating synergy realization and cost measures to deliver strong profitability, while advancing the transformation of the combined organization at a remarkable pace through an expanded leadership structure and an optimized operational footprint.”

Barend Fruithof, Chairman and Group CEO

“We remain focused on increasing profitability and driving sustainable gross margin improvement. We accelerated operational improvements and maintained strict cost discipline to mitigate margin pressure in the short term, while executing sales pricing measures that will drive margin recovery in 2027.”

Marco Portmann, Group CFO
7:01 AM ET 8-K
Financial Results TScan Therapeutics, Inc. TCRX

TScan Therapeutics Financial Results

TScan Therapeutics reported third quarter 2026 financial results and announced a strategic reorganization to prioritize its in vivo-engineered TCR-T cell therapy program for solid tumors. The company has paused enrollment in its Phase 3 ALLOHA-2 study for heme malignancies to conserve capital and is actively seeking strategic partners for its heme and autoimmunity programs.

“This quarter marked an important step in accelerating TScan’s solid tumor program. We are concentrating all our efforts on our in vivo-engineered TCR-T cell approach for solid tumor indications, where we see an opportunity to bring an exciting new treatment modality to patients in desperate need of better treatment options.”

Gavin MacBeath, Ph.D., Chief Executive Officer
7:01 AM ET 8-K
Financial Results Lithium Americas Corp. LAC

Lithium Americas Financial Results

Lithium Americas Corp. reported its Q3 2026 financial results, highlighting a cash position of $1.3 billion and continued construction progress at its Thacker Pass lithium project in Nevada. The company reported that Phase 1 of the project remains on track for mechanical completion in late 2027 with a definitive capital cost estimate of $3.83 billion.

Term
Q3 2026

“Thacker Pass is one of the largest construction projects in Nevada and is on track to deliver America's largest fully integrated source of domestic battery-quality lithium carbonate. Thacker Pass represents more than a strategic supply chain asset, it is an investment in Nevada workers and local communities, creating meaningful, family-supporting jobs. We are proud to build a lithium operation expected to help secure America’s critical mineral independence, which is key for national security.”

Jonathan Evans, President and Chief Executive Officer of Lithium Americas

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.